Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Blues TEC Issues Negative Review Of Cyberonics’ VNS Therapy For Depression

This article was originally published in The Gray Sheet

Executive Summary

The BlueCross BlueShield Association's Technology Evaluation Center (TEC) says there is insufficient evidence to conclude that Cyberonics' VNS Therapy improves net health outcomes of patients with treatment-resistant depression

You may also be interested in...



Cyberonics Seeks Coverage For Anti-Depression Implant In Select Patients

Cyberonics is pursuing national coverage of its VNS Therapy implant for treatment-resistant depression in a select group of patients, despite continued payor skepticism as to the technology's effectiveness

Cyberonics Seeks Coverage For Anti-Depression Implant In Select Patients

Cyberonics is pursuing national coverage of its VNS Therapy implant for treatment-resistant depression in a select group of patients, despite continued payor skepticism as to the technology's effectiveness

Cyberonics Nabs Approval For Depression Device, Plans For Reimbursement

Cyberonics predicts reimbursement for VNS Therapy for treatment-resistant depression (TRD) will be fully secured by 2007, despite encountering protracted difficulties in gaining FDA approval

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel